Medical Science Liaison (MSL) / Senior Medical Science Liaison (Sr. MSL), Oncology - CO, KS and MO
Eisai
Summary
The Medical Science Liaison (MSL) / Senior Medical Science Liaison (Sr. MSL) is a field-facing representative of US Medical Affairs with a primary responsibility of engaging in the exchange of scientific data and other medical and/or scientific information with external customers (healthcare providers, researchers, professional organization leadership, and population-based decision makers) in the areas of Eisai's interest.
Job description
Essential Functions
Product/Therapeutic Area Support to External Stakeholders
- Act as the primary clinical/scientific resource to Healthcare Providers (HCPs) in the territory for information pertaining to disease state and Eisai's product(s) to ensure awareness and understanding.
- Serve as a conduit for accurate and updated clinical, scientific and medical information between Key Opinion Leaders (KOLs)/investigators and the company's Medical Affairs and development groups.
- Establish, foster, cultivate and maintain peer relationships with KOLs in the therapeutic areas in which Eisai has current and future interests.
- Share knowledge and participate in scientific exchanges and interactions with identified KOLs.
- Present clinical, scientific and economic data on Eisai's products and relevant therapeutic areas to population-based decision-makers, as requested.
- Support assigned professional congresses in accordance with MSL plan.
- Be prepared to lead congress coverage efforts, including coordination of all MSL/Sr. MSL activities, as required and assigned by the management.
- Identify and report key scientific, clinical and research insights from KOLs to Medical Affairs.
- Develop, implement and present to management plans to support Medical Affairs strategic direction for assigned territory.
Training/Education Resource
- Maintain and demonstrate thorough and up-to-date knowledge of disease state, study methodology, clinical information, and product data.
- Demonstrate full knowledge of and ability to execute on approved medical platforms/strategies and MSL initiatives.
- Serve as technical/scientific subject matter resource to Eisai commercial personnel, if requested.
- Teach, coach and mentor new or less experienced MSLs; assist with supervision/performance evaluation; assume responsibility for special projects.
- Provide valuable contributions to the organization including leadership and strategic planning.
Research Support
- Facilitate review and follow up of submitted Investigator-Initiated Studies (IISs) and assist with Eisai sponsored trials.
- Serve as primary contact to external investigators who submit IISs.
- The MSL may also be involved with providing recommendations for site selection and scientific expertise to Investigators involved in company sponsored post-marketing studies.
Professional Organization Support
- Lead field medical efforts in support of Eisai's collaboration and interactions with professional organizations/societies & advocacy groups, as required.
Requirements
- Advanced, terminal Doctorate level (D-level) degree in medical or health sciences (e.g. MD, PhD, PharmD, DPH, EdD)
- For MSL: 0-3 years of experience in pharma/biotech industry/clinical pharmacist/research/related experience in a scientific or clinical setting, preferably as MSL
- For Sr. MSL: minimum of 3 years MSL experience in Oncology/Hematology
- Strong broad-based scientific and pharmaceutical knowledge
- Knowledge of treatment guidelines, clinical research processes, FDA regulations and OIG guidelines
- Knowledge and experience within Eisai desired therapeutic area(s)
- Established relationships with key opinion leaders and knowledge of institutions in therapeutic areas of interest
- Excellent presentation and teaching skills
- Strong overall written and verbal communication skills
- Demonstrated ability to assess issues and think strategically
- Demonstrated ability and experience working cross-functionally
- Demonstrated ability to anticipate, organize, plan and handle multiple changing priorities
- Demonstrated ability to work independently and not requiring close supervision while adhering to Medical Affairs strategic direction
- Ability and interest in coaching and mentoring less experienced MSLs
- Ability to lead and motivate team members without a direct reporting relationship
- Ability and interest in leading and participating in projects while effectively balancing projects with field work
- Demonstrated ability to analyze complex situations and proactively identify opportunities/issues
- Sound computer skills including applications for word processing, producing slide materials and working with spreadsheets
- Previous established relationships with KOLs in Oncology/Hematology
- Possesses an understanding of the pharmaceutical corporate environment and appreciation for commercial operations, including marketing and sales strategies
- Capable of engaging in frequent business travel (approximately 60% of time)
- Possesses and maintains a valid driver's license
- Clinical trial development and drug launch experience is strongly preferred
Benefits
- Annual Incentive Plan
- Long Term Incentive Plan
- Health Insurance
- Retirement Benefits
Company overview
Eisai Co., Ltd. is a leading Japanese pharmaceutical company headquartered in Tokyo, Japan, with a significant global presence through its U.S. subsidiary Eisai Inc. Founded in 1941, Eisai has grown to become a major player in the pharmaceutical industry with approximately 10,000 employees worldwide, including about 1,500 dedicated to research and development. The company operates as a fully integrated pharmaceutical business with strategic focus areas in neurology and oncology, particularly specializing in dementia-related diseases, neurodegenerative disorders, and cancer treatments. Eisai is publicly traded on the Tokyo Stock Exchange and is a constituent of both the TOPIX 100 and Nikkei 225 indices. The company is renowned for its innovative drug portfolio including Aricept (donepezil) for Alzheimer's disease, Lenvima (lenvatinib) for various cancers, and the recently approved Leqembi (lecanemab) for Alzheimer's treatment. Eisai's corporate philosophy centers on its 'human health care' (hhc) mission, which prioritizes patient needs and drives the company's research and development efforts across multiple global locations including Japan, the United States, United Kingdom, and other key markets.